Josh Real advises clients at the intersection of business and cutting-edge technology, particularly on transactions within the digital health, healthcare and life sciences, and technology sectors.

Josh leverages extensive experience, cultivated both in-house and as external counsel, to lead multidisciplinary teams on business-defining deals involving:

  • Technology and intellectual property licensing and transfers
  • Strategic partnerships and joint ventures
  • Payor contracting and other enterprise sales
  • Outsourced, joint, and other R&D arrangements
  • Medical device, pharmaceutical, supplement, and other manufacturing and supply
  • Consumer-facing product terms and waivers
  • Retail, broker, distribution, and other product promotion and resale arrangements
  • White-labeled technology, supplement, and other product licensing, distribution, and resale
  • Laboratory partnerships
  • Product counseling
  • IP, commercial, and technology aspects of M&A transactions
  • Technology escrow arrangements

Before joining Latham, Josh was Assistant General Counsel and Director of Business Development for Everly Health.

Josh’s experience from before joining Everly Health includes representing:

  • A hospital system in its EHR and other platform licensing, consulting services, and other IT transactions*
  • A nonprofit in the development of its proprietary case management platform and in its commercialization and outbound licensing of the platform to Native American tribes, governmental health systems, and others*
  • A group of professors in the founding of a startup to develop and commercialize an RNA-based gene editing platform, including in negotiating the associated foundational inbound licenses from the universities at which they had done the underlying research*
  • A pharmaceutical company in the sale of its consumer health business to another pharmaceutical company, including drafting and negotiating agreements for the ongoing manufacture and supply of various OTC products*
  • A multinational technology company in the negotiation of its primary and second-source manufacturing and supply arrangements for its wearable medical device*
  • A client in its outsourced R&D and inbound licensing of technology for its wearable consumer product with medical device capabilities*
  • A buyer in its confidential nine-figure acqui-hire of multiple divisions of employees and acquisition of certain technology those employees used to perform their jobs, including negotiating a transition services agreement to migrate and license the customized platform the employees used*
  • A multinational technology company in its acquisition of an AI-powered voice agent startup*
  • A multinational technology company in its development and license agreement with an AI image recognition startup and in its parallel investment in such startup*
  • Several multinational companies on all aspects of their semiconductor-related transactions, including complex licensing, manufacturing, and supply matters*
  • A multinational technology company in its technology acquisition and custom infrastructure deals*
  • A leading customer relationship management software company in numerous technology, hardware, software, and commercial deals*
  • A leading display panel manufacturer in a series of multibillion-dollar agreements with two leading consumer electronics companies to develop, manufacture, and supply displays for smartphones, tablets, and notebook and desktop computers*
  • A social media company in its back-to-back billion-dollar cloud services agreement with leading technology companies as well as related renewals*
  • A financial services company in its development and partnership agreement with, and related investment in, an institutional trading platform provider for digital assets and cryptocurrencies*

*Matter handled prior to joining Latham

Bar Qualification

  • California